HARBIN GLORIA PHARMACEUTICALS Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Leifeng Guo
Chief executive officer
CN¥2.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.2yrs |
| CEO ownership | 1.0% |
| Management average tenure | 2.4yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO
Leifeng Guo (51 yo)
2.2yrs
Tenure
CN¥2,159,600
Compensation
Mr. Leifeng Guo is General Manager at Harbin Gloria Pharmaceuticals Co., Ltd since December 2022. He served as a Director of Shanghai Allist Pharmaceuticals Co., Ltd. until April 6, 2023.Mr. Guo served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | no data | CN¥2.16m | 0.96% CN¥ 54.7m | |
| Deputy GM & Non-Independent Director | 3yrs | CN¥1.86m | no data | |
| Deputy GM & Secretary of the Board | 4.2yrs | CN¥1.15m | 0.046% CN¥ 2.6m | |
| Accounting Supervisor | no data | no data | no data | |
| Deputy General Manager | 1.8yrs | no data | 0.10% CN¥ 5.9m | |
| Deputy General Manager | 1.5yrs | no data | 0.10% CN¥ 5.9m |
2.4yrs
Average Tenure
45yo
Average Age
Experienced Management: 002437's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 2.2yrs | CN¥2.16m | 0.96% CN¥ 54.7m | |
| Deputy GM & Non-Independent Director | 2.2yrs | CN¥1.86m | no data | |
| Non-Independent Chairman | 4.5yrs | CN¥2.16m | 0.96% CN¥ 54.7m | |
| Director | 16.6yrs | CN¥1.90m | 0.39% CN¥ 22.4m | |
| Independent Director | 2.1yrs | CN¥200.00k | no data | |
| Employee Representative Supervisor | 4.7yrs | no data | no data | |
| Independent Director | 2.1yrs | CN¥200.00k | no data | |
| Independent Director | 2.1yrs | CN¥200.00k | no data | |
| Chairman of the Supervisory Board | 1.5yrs | no data | no data | |
| Supervisor | 1.5yrs | no data | no data |
2.1yrs
Average Tenure
48yo
Average Age
Experienced Board: 002437's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/27 19:21 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HARBIN GLORIA PHARMACEUTICALS Co., LTD is covered by 13 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Shanshan Li | China Merchants Securities Co. Ltd. |